Seoul, South Korea

Hee Jung An

USPTO Granted Patents = 7 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Gyeonggi-do, KR (2016)
  • Seoul, KR (2018 - 2024)

Company Filing History:


Years Active: 2016-2024

Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Hee Jung An: Innovator in NK Cell Culture and Cancer Therapy**

Introduction

Hee Jung An is a notable inventor based in Seoul, South Korea, known for his significant contributions to the field of immunotherapy. With a remarkable portfolio of 7 patents, he is at the forefront of innovative solutions for cancer treatment. His research focuses primarily on natural killer (NK) cells, which play a critical role in the immune system's defense against tumors.

Latest Patents

One of Hee Jung An's latest patents is a composition for culturing NK cells and a method for culturing NK cells using this composition. This invention involves culturing NK cells from peripheral blood mononuclear cells in a medium enriched with specific interleukins - IL-15, IL-18, and IL-27. His innovative approach facilitates the proliferation and activation of NK cells, enhancing their ability to induce cancer cell apoptosis and effectively kill cancer cells. This methodology opens doors for developing NK cells as an effective therapeutic option in cancer prevention and treatment.

Career Highlights

Throughout his career, Hee Jung An has worked with esteemed organizations such as Sungkwang Medical Foundation and CMG Pharmaceutical Co., Ltd. These experiences have helped him refine his expertise and contribute significantly to the field of medical research and development.

Collaborations

Hee Jung An's work is complemented by collaborations with talented individuals like Ah Young Kwon and Yong Wha Moon. These partnerships have fostered a collaborative environment that enhances the innovative process and contributes to groundbreaking research in medical therapy.

Conclusion

Hee Jung An's innovations and patent portfolio have set a benchmark in the research and application of NK cell culture for cancer therapies. His continued efforts in this critical area of health science highlight the importance of inventors in advancing medical technology and their impact on improving treatment outcomes for patients battling cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…